IL-33 in the basolateral amygdala integrates neuroinflammation into anxiogenic circuits via modulating BDNF expression

Brain Behav Immun. 2022 May:102:98-109. doi: 10.1016/j.bbi.2022.02.019. Epub 2022 Feb 16.

Abstract

Hyper-inflammatory reaction plays a crucial role in the pathophysiology of depression and anxiety disorders. However, the mechanisms underlying inflammation-induced anxiety changes remain poorly understood. Here, we showed that in the lipopolysaccharide (LPS)-induced anxiety model, Interleukin (IL)-33, a member of the IL-1 family, was up-regulated in the basolateral amygdala, and IL-33 deficiency prevent anxiety-like behavior. Overexpression of IL-33 in amygdalar astrocytes led to anxiety-like response via repressing brain-derived neurotrophic factor (BDNF) expression. Mechanically, IL-33 suppressed BDNF expression through NF-κB pathway to impair GABAergic transmission in the amygdala and NF-κB inhibitor abolished the effect of IL-33 on anxiety. Administration of an inverse GABAA receptor agonist increased the anxiety of IL-33- deficient mice. These results reveal that inflammatory response can activate anxiogenic circuits by suppressing BDNF and GABAergic neurons transmission, suggesting that IL-33 in basolateral amygdalar is a linker between inflammation and anxiety.

Keywords: Amygdala; Anxiety; BDNF; IL-33.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anxiety / metabolism
  • Basolateral Nuclear Complex* / metabolism
  • Basolateral Nuclear Complex* / pathology
  • Brain-Derived Neurotrophic Factor* / biosynthesis
  • Brain-Derived Neurotrophic Factor* / metabolism
  • Inflammation / metabolism
  • Inflammation / pathology
  • Interleukin-33* / metabolism
  • Mice
  • NF-kappa B* / metabolism
  • Neuroinflammatory Diseases / metabolism

Substances

  • Bdnf protein, mouse
  • Brain-Derived Neurotrophic Factor
  • Il33 protein, mouse
  • Interleukin-33
  • NF-kappa B